<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-NER-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Niger (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Niger (the): Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="FR">Cette activit&#xE9; d&#xE9;taille notre travail sur le Aide cibl&#xE9;e aux pays en Niger (le), gr&#xE2;ce &#xE0; la mise &#xE0; disposition des donn&#xE9;es budg&#xE9;taires et des transactions. Nous fournissons &#xE9;galement les documents pertinents qui guident ces activit&#xE9;s que sont les formulaires de demande de soutien fournis par le gouvernement de Niger (le) ainsi que les lettres de d&#xE9;cisions &#xE9;mises par Gavi, pour progresser. Ces documents d&#xE9;crivent les activit&#xE9;s, les objectifs ainsi que les b&#xE9;n&#xE9;ficiaires.</narrative>
   <narrative xml:lang="EN">This activity details our work on Targeted country assistance in Niger (the) through the provision of budget and transaction data.  We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Niger (the), as well as the decision letter(s) issued by Gavi, for progress.  These documents describe the activities, the objectives as well as the beneficiaries.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Expertise France</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">GIE Vaccilog</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Niger (the)</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="NE" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="NE" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Niamey</narrative>
   </name>
   <administrative code="NE" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>13.5125 2.11178</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">1917052</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">3691792</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">3006127</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">517666</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="NERPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">12000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">313147</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">97845</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">51745</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">122978</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">853789</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">457706</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">314661</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">139874</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">98565</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">351269</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-SAMBOU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">27457</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">27644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1382196</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-VACCILOG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">70774</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1079352</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">367763</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">170410</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">275686</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">452450</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-SAMBOU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">59101</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">30476</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">945252</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-VACCILOG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">12</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">704976</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">87625</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">14668</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">236315</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">179057</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000858">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">9000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">3000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000859">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">234860</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">78287</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">314661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">104887</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">262876</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900002697">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">15925</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002606">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">3445</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">26353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900004170">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">19463</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900007319">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">9535</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000913">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">10336</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000911">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">3912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000912">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">8604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002816">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">5578</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002817">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">8098</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">8977</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003067">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9260</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003065">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9289</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003066">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9959</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-1248</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-1414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-821</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-8628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1248</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">821</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">8628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000402">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-10"></transaction-date>
   <value currency="USD" value-date="2021-03-10">9366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000406">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">8331</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000407">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9319</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000405">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000403">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">9120</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004683">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">7650</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004685">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">8432</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004686">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">8825</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004684">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">9040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005689">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-02"></transaction-date>
   <value currency="USD" value-date="2021-11-02">8775</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005688">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-02"></transaction-date>
   <value currency="USD" value-date="2021-11-02">9007</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007525">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">5250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007557">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">1400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007558">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">4900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007559">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">7700</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000752">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000751">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">9689</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005513">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">20399</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000814">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-29"></transaction-date>
   <value currency="USD" value-date="2021-04-29">6574</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-10"></transaction-date>
   <value currency="USD" value-date="2021-05-10">21608</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003858">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-17"></transaction-date>
   <value currency="USD" value-date="2021-08-17">5965</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004939">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-05"></transaction-date>
   <value currency="USD" value-date="2021-10-05">16688</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">98173</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001004">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">47085</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001166">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-4024</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-84416</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000552">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-26"></transaction-date>
   <value currency="USD" value-date="2019-11-26">76808</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-01"></transaction-date>
   <value currency="USD" value-date="2019-12-01">45887</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000181">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-30"></transaction-date>
   <value currency="USD" value-date="2020-01-30">16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">85198</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-25624</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-49603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">25624</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">49603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000078">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001428">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">7294</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001428">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">85198</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000266">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-04"></transaction-date>
   <value currency="USD" value-date="2021-05-04">48923</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001922">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-27"></transaction-date>
   <value currency="USD" value-date="2021-09-27">41082</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006718">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">111336</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006717">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">41082</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006715">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">49599</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">42627</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007321">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">5837</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000556">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000553">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">1554</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000554">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="USD" value-date="2020-03-31">1403</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001674">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">1546</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002495">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">135</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002074">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-25"></transaction-date>
   <value currency="USD" value-date="2020-06-25">247</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-13"></transaction-date>
   <value currency="USD" value-date="2020-08-13">1607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002494">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-07"></transaction-date>
   <value currency="USD" value-date="2020-09-07">1607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">1668</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004071">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-08"></transaction-date>
   <value currency="USD" value-date="2020-10-08">778</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-03"></transaction-date>
   <value currency="USD" value-date="2020-11-03">1668</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004672">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-17"></transaction-date>
   <value currency="USD" value-date="2020-11-17">1690</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004673">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-17"></transaction-date>
   <value currency="USD" value-date="2020-11-17">395</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004969">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-03"></transaction-date>
   <value currency="USD" value-date="2020-12-03">1704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004970">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-03"></transaction-date>
   <value currency="USD" value-date="2020-12-03">1731</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-2698</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">2698</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000174">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-16"></transaction-date>
   <value currency="USD" value-date="2021-02-16">1734</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001124">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1541</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001125">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001126">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1707</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000598">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">1730</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001916">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-03"></transaction-date>
   <value currency="USD" value-date="2021-05-03">1716</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003039">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">1695</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003061">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">1695</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002521">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">956</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003717">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">1691</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003715">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">2237</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003718">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">953</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004592">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">2233</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006154">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">2118</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006885">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">2138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006883">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">4262</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">3150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">3225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">375</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">4688</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000860">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">800427</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">106724</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">708921</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">513189</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">236307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">708945</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004581">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">9401</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005105">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">22193</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005104">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">33457</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005312">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">3717</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000861">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">416096</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">503412</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001655">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">55480</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">478851</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">83902</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">537172</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <related-activity ref="47122-NER" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#NAME?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 50% of mapped non-immunization and under-used health sector partners at the national level engaged in the multi-sectoral approach to reaching zero dose populations and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="- Conduct mapping of non-immunization and other under-used health sector stakeholders in Nigeria that are relevant in rolling out an integrated multisectoral approach for reaching zero dose and missed communities
- Support the NERICC and EPI team in the design, development and deployment of multi-sectoral interventions targeted at reaching zero dose children and missed communities, in collaboration with other partners">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Financial reports of utilization of Gavi funds across Gavi-supported programmes, including state budget, submitted every quarter (or as required)
?	Report on execution of activities and funds including the absorption rate per budget item
?	Request for reprogramming or reallocation submitted to Gavi in a timely manner
?	Timely submission of request for funding to WHO and UNICEF
?	Harmonization of HSS and NERICC workplans conducted 
?	Required budgets for NERICC, NLWG, Non-Polio SIAs and other programmes developed, agreed with WHO and UNICEF finance teams and submitted on time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Proactively monitor the execution of activities and utilization of Gavi funds by the RI and SIA teams, for NPHCDA and partners and provide weekly reports to the Gavi SCM and NPHCDA leadership
?	Support NERICC and other teams (where necessary) in the development of appropriate workplans and budgets for Gavi-funded activities
?	Track utilization of Gavi funds for the intended purposes and flag any potential issues related to execution of Gavi funds to Gavi teams.
?	Provide strategic efforts towards harmonisation, integration, when feasible, and ensure complementarities across the multiple programmes and/or projects funded by Gavi and by other partners.
?	Support identification and implementation of synergistic approaches that will deliver maximum impact and value for money in the roll-out of health system strengthening plans
?	Strengthen cross-communication and collaboration among Gavi-funded organizations (WHO, UNICEF, US-CDC, etc)
?	Provide systematic support in optimization of planned activities to eliminate/minimize wastage of resources
?	Proactively flag any delays in implementation or release of funds and provide options to address the bottlenecks and improve the absorption of funds.
?	Support NERICC and the NPSIA teams to report on execution of activities, Gavi grants and fund utilization and absorption to the Core Group, the Inter Agency Coordinating Committee (ICC) and the Gavi Secretariat.
?	Support the development of state-specific plans for improving RI and PHC, in line with the NSIPSS as well as support states to develop LGA-specific plans to improve RI and PHCMonthly reporting to Gavi and proactive reporting on specific issues and/or identified risks">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Results of data triangulation presented monthly to the NERICC and Core Group
- State-level analysis shared with all states
- Action plans to address issues flagged by the analysis developed by the states and incorporated into state annual operational plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Approach for multi-data triangulation developed and approved by the NERICC and Core Group to identify zero dose populations and support targeted deployment of interventions to reduce number of zero dose children in Nigeria</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">JSI participated in Project Management Team meetings</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Actively support all aspects of cold chain management and planning for the CCEOP">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan for cold room mapping and transport monitoring developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the DI for temperature monitoring during transport and cold room mapping in national/regional levels">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts ont mis en ?uvre les activites de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; dans la mise en oeuvre des activites innovantes de vaccination dans les 19 districts sanitaires prioritaires de responsablit&#xE9; de l&apos;UNICEF couverts par les 4 bureaux de zone UNICEF">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts ont &#xE9;labor&#xE9; des Plans d&apos;Action Annuel (PAA) prenant en compte les activites de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; dans la mise en oeuvre des activites innovantes de vaccination dans les 19 districts sanitaires prioritaires de responsablit&#xE9; de l&apos;UNICEF couverts par les 4 bureaux de zone UNICEF">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mission d&apos;appui du bureau r&#xE9;gional (WCARO) &#xE0; la r&#xE9;vision de la cartographie r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la r&#xE9;vision de la cartographie du processus de budg&#xE9;tisation des achats de vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training/capacity-building activities to strengthen immunization costing/ planning/budgeting conducted. NPHCDA and SPHCDA finance staff from 4/8 Gavi priority states trained in HACT modalities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">4/8 states started implementing Gavi accountability framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training materials developed, training plan prepared, and budget secured.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">States teams oriented on Gavi accountability framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mission d&apos;appui de bureau r&#xE9;gional (WCARO) &#xE0; l&apos;examen du budget r&#xE9;alis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutenir l&apos;examen du budget annuel et pluriannuel d&apos;achat des vaccins, y compris, l&apos;&#xE9;laboration d&apos;un mod&#xE8;le de budg&#xE9;tisation normalis&#xE9;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 reunions du GTCV organis&#xE9;es avec au moins 2 avis (recommandations) emis pour orienter le programme de vaccination dans la mise en ?uvre des activit&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour le fonctionnement du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mise en ?uvre d&apos;au moins 01 avis initi&#xE9;e; 

Au moins 3 r&#xE9;nions du GTCV avec au moins 3 avis (recommandations) emis pour orienter le programme de vaccination dans la mise en ?uvre des activit&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour le fonctionnement du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">01 supervision de qualit&#xE9; conduite par au moins 50% des districts brief&#xE9;s; 

34 cadres de districts sanitaires prioritaires (2 cadres de 17 districts ) sont brief&#xE9;s sur la conduite des supervisions int&#xE9;gr&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 33 districts sanitaires prioritaires (Coaching par les pairs) dans la conduite de supervisions int&#xE9;gr&#xE9;es des formations sanitaires avec l&apos;appui du niveau central et regional">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 reunions de CCIA statutaires sont tenues avec rapport disponibles au niveau central</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique au fonctionnement du CCIA au niveau central et dans les regions d&apos;Agadez, de Tillab&#xE9;ry et de Dosso">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3 reunions de CCIA ordinaires tenues au niveau central et 1 reunion ordinaire tenue au niveau des regions d&apos;Agadez, de Tillabery et de Dosso avec rapport dsponibles et 80% des recommandations mise en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique au fonctionnement du CCIA au niveau central et dans les regions d&apos;Agadez, de Tillab&#xE9;ry et de Dosso">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">32 cadres de districts sanitaires prioritaires (2 cadres de 16 districts ) sont brief&#xE9;s sur la conduite des supervisions int&#xE9;gr&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 33 districts sanitaires prioritaires (Coaching par les pairs) dans la conduite de supervisions int&#xE9;gr&#xE9;es des formations sanitaires avec l&apos;appui du niveau central et regional">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">4 r&#xE9;nions du GTCV organis&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour renforcer le secr&#xE9;tariat du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour renforcer le secr&#xE9;tariat du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% completion of CCEOP PMT workplans across implementing states (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="11. Technical support for the CCEOP deployment and implementation">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="11. Technical support for the CCEOP deployment and implementation">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% Procurement and distribution of vaccines and devices in line with 2020 forecast
100% Forecast accuracy monitoring and evaluation (quarterly)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5. Support  state specific forecasting  in line with the revised immunization coverage targets for states">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5. Support  state specific forecasting  in line with the revised immunization coverage targets for states">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre &#xE0; temps</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI au d&#xE9;veloppement et &#xE0; la mise en ?uvre du plan d&apos;am&#xE9;lioration de la gestion efficace des vaccins issu des r&#xE9;sultats de la GEV externe conduite en  2020">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI au d&#xE9;veloppement et &#xE0; la mise en ?uvre du plan d&apos;am&#xE9;lioration de la gestion efficace des vaccins issu des r&#xE9;sultats de la GEV externe conduite en  2020">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les equipements de la chaine du froid de l&apos;ann&#xE9;e 2 du CCEOP sont receptionn&#xE9;s, distribu&#xE9;s, install&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du CCEOP et le suivi de la gestion des equipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du CCEOP et le suivi de la gestion des equipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des Coordonnateurs D&#xE9;partementaux  Immunisations et agents de sant&#xE9; sont form&#xE9;s sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT ) dans les 33 districts prioritaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Coordonnateurs D&#xE9;partementaux des Immunisations et des agents de sante offrant la vaccination sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT, outil de l &apos; inventaire et de l&apos;analyse des gaps ECF) dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Coordonnateurs D&#xE9;partementaux des Immunisations et des agents de sante offrant la vaccination sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT, outil de l &apos; inventaire et de l&apos;analyse des gaps ECF) dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">SOPs disemminated and personnel trained on revised processes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">iSC Roadmap finalized and 2021 annualized NLWG work plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="15. TA to support development of iSC Roadmap (Year 2)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?25% completion of ISC systems redesign optimisation plan (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="13. Technical support for ISC systems redesign, including warehousing and distribution optimisation
 Other activities related to ISC2 mission">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="13. Technical support for ISC systems redesign, including warehousing and distribution optimisation
 Other activities related to ISC2 mission">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% completion of annualised NLWG projects to be implemented at the state level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6. Technical liaisons between the NLWG and SLWGs, withinzonal catchment areas, for implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6. Technical liaisons between the NLWG and SLWGs, withinzonal catchment areas, for implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">PSC Report submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="10. Physical Stock Counting Exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts urbains et semi-urbains identif&#xE9;s ont mis en eouvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre de la strat&#xE9;gie urbaine au niveau des r&#xE9;gions de Dosso et Zinder (3 districts urbains et semi urbains Magaria, Gaya, Dosso)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre de la strat&#xE9;gie urbaine au niveau des r&#xE9;gions de Dosso et Zinder (3 districts urbains et semi urbains Magaria, Gaya, Dosso)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre les strat&#xE9;gies de vaccination en zones d&#xE9;sertiques et d&apos;ins&#xE9;curit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Agadez, Tillab&#xE9;ry, Zinder (Aderbissenat, Arlit, Ingall, Abala, Ayerou, T&#xE9;ra, Bankilar&#xE9;, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Agadez, Tillab&#xE9;ry, Zinder (Aderbissenat, Arlit, Ingall, Abala, Ayerou, T&#xE9;ra, Bankilar&#xE9;, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 35% increase number of LGA 18 priority states , with accpetable LQAS results at &gt;80%
2. 80% of States with Penta3 coverage of 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide State specific Technical and Operational support for the management and coordination of SERICCs to improve RI peformance in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide State specific Technical and Operational support for the management and coordination of SERICCs to improve RI peformance in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 80% of the 18 low performing states receiving real time support and onsite supervision from National Teams
2. 60% of 19 medium to high perform states sensitised on OIRIS and NERICC approach</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support to the PM to Coordinate and Monitor Quality Implementation of OIRIS strategies 18 low performing and 19 medium and high performing states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support to the PM to Coordinate and Monitor Quality Implementation of OIRIS strategies 18 low performing and 19 medium and high performing states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) at least 80% of service delivery strategies implemented

3) NToT reports on capacity building</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to the Service Delivery Team in NERICC to guide the development and assessment of operational plans of states
2. Manage the conduct of RI-LQAS  dictated by NERICC and facilitating compilation of relevant reports
3. Support the implementation of training interventions to build the capacity of lower level staff on immunisation">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to the Service Delivery Team in NERICC to guide the development and assessment of operational plans of states
2. Manage the conduct of RI-LQAS  dictated by NERICC and facilitating compilation of relevant reports
3. Support the implementation of training interventions to build the capacity of lower level staff on immunisation">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro, Abalak, Bermo, Malbaza, Tessaoua, G. Roumdji, Madaoua, Tahoua, Bouza)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro, Abalak, Bermo, Malbaza, Tessaoua, G. Roumdji, Madaoua, Tahoua, Bouza)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts urbains et semi-urbains identif&#xE9;s ont mis en eouvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les r&#xE9;gions de Niamey, Maradi et Tahoua (6 districts urbains et semi urbains B.Konni ; Maradi Ville, Niamey 5, Niamey 3, Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les r&#xE9;gions de Niamey, Maradi et Tahoua (6 districts urbains et semi urbains B.Konni ; Maradi Ville, Niamey 5, Niamey 3, Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre les strat&#xE9;gies de vaccination en zones d&#xE9;sertiques et d&apos;ins&#xE9;curit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Diffa et Tahoua(Bosso, N&apos;gourti, Main&#xE9; Soroa et Tilia)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Diffa et Tahoua(Bosso, N&apos;gourti, Main&#xE9; Soroa et Tilia)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">72 districts ont &#xE9;labor&#xE9; et mis en oeuvreles activites de vaccination pour ameliorer la couverture vaccinale</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la planification, la mise en oeuvre et le suivi des activites  de vaccination tant au niveau national qu&apos;au niveau regional et district pour augmenter la couverture vaccinale tant en milieu urbain qu&apos;en milieu rural">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la planification, la mise en oeuvre et le suivi des activites  de vaccination tant au niveau national qu&apos;au niveau regional et district pour augmenter la couverture vaccinale tant en milieu urbain qu&apos;en milieu rural">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The states are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts prioritaires  ont mis en ?uvre leur microplan PEV ACD/CEA et les paquets d&apos;intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 27  ECD des districts prioritaires (Region de Maradi, Zinder, Diffa, Agadez et Tahoua) dans l&apos;elaboration  des micro plans PEV sur la base du guide ACD/CEA et  dans la mise en ?uvre des paquets d&apos;intervention dans les 33 districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 27  ECD des districts prioritaires (Region de Maradi, Zinder, Diffa, Agadez et Tahoua) dans l&apos;elaboration  des micro plans PEV sur la base du guide ACD/CEA et  dans la mise en ?uvre des paquets d&apos;intervention dans les 33 districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% increase in awareness of immunization through community based channels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach to strengthen demand of routine immunization, and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program, SIAs and new vaccine introduction. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach adopted to strengthen demand of routine immunization, SIAs and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach to strengthen demand of routine immunization, and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Lessons learned on CE implementation in current States implementing CE documented.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Assess, revitalize and document implementation of community engagement strategy in 8 priority States. 2. Develop CE sustainability framework and mechanism, outlining key strategies for integration to inform CE roll out in targeted States.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La formation des 3 pools a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux 3 pools de formation des OSC sur les Directives du PEV, la Recherche des perdus de vue et l&apos;engagement communautaire dans 33 Districts Sanitaires Prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Modules de formation pour les OSC disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux 3 pools de formation des OSC sur les Directives du PEV, la Recherche des perdus de vue et l&apos;engagement communautaire dans 33 Districts Sanitaires Prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan strat&#xE9;gique de communication 2017-2021 est r&#xE9;vis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le developpement de la Demande de la vaccination dans l&apos;encadrement du niveau central et d&#xE9;centralis&#xE9;, dans le developpement et la mise en oeuvre des directives et procedures en communication pour la vaccination">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical support on integrated community based interventions provided in implementing States.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CE Strategy rolled out in priority States.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Line listing used for action</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. TA to support Community engagement strategy and conduct line-listing of newborns and eligible children in every settlement">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. TA to support Community engagement strategy and conduct line-listing of newborns and eligible children in every settlement">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">11 DS ont r&#xE9;alis&#xE9; des Assembl&#xE9;es Villageoises de leurs CSI avec liste nominative enterinee par la chefferie traditionnelle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evidence based communication plans in priority states developed and adapted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support on appropriate use of communication approaches for social development, aimed at individual, community behaviour change, collective action and policy advice. 2. Support review and development of tools for generating social and behavioral data to guide appropriate communication approaches.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and guidance for generating social and behavioural data adapted and developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support on appropriate use of communication approaches for social development, aimed at individual, community behaviour change, collective action and policy advice. 2. Support review and development of tools for generating social and behavioral data to guide appropriate communication approaches.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integrated communication packages for resouces persons developed and adapted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health worker BCC strategy rolled out at subnational levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support to planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers at various implementation levels e.g, IPCI. 2. Provide technical support in development and design of health worker BCC package and toolkit to guide communication interventions with caregivers..">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health worker BCC strategy, costed implementation plan and M,E, and reporting plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support to planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers at various implementation levels e.g, IPCI. 2. Provide technical support in development and design of health worker BCC package and toolkit to guide communication interventions with caregivers..">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evidence based CE sustainability framework developed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Assess, revitalize and document implementation of community engagement strategy in 8 priority States. 2. Develop CE sustainability framework and mechanism, outlining key strategies for integration to inform CE roll out in targeted States.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rota vaccine introduced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7. Communication support in the  implementation SIAs (Men A, Measles and Yellow Fever campaigns and New Vaccines Introduction (MCV2) in the northern states and rota vaccine introduction nationwide.  Supports disease outbreak response and supervision of  state-level community engagement for Routine Immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7. Communication support in the  implementation SIAs (Men A, Measles and Yellow Fever campaigns and New Vaccines Introduction (MCV2) in the northern states and rota vaccine introduction nationwide.  Supports disease outbreak response and supervision of  state-level community engagement for Routine Immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">22 DS ont r&#xE9;alis&#xE9; des Assemblees Villageoises de leurs CSI avec liste nominative enterinee par la chefferie traditionnelle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des agents communautaires sont form&#xE9;s sur le suivi communautaire de la vaccination des enfants de 0-23 mois et pour la d&#xE9;claration des naissances &#xE0; travers des registres communautaires dans les 33 districts prioritaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la mise en place des registres communautaires pour le suivi communautaire de la vaccination et autres activit&#xE9;s de sant&#xE9; ainsi que la d&#xE9;claration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des agents communautaires menent des activit&#xE9;s de suivi communautaire des enfants de 0-23 mois et de d&#xE9;claration des naissances dans les 33 districts sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la mise en place des registres communautaires pour le suivi communautaire de la vaccination et autres activit&#xE9;s de sant&#xE9; ainsi que la d&#xE9;claration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les acteurs impliques dans la vaccination sont formes sur les risques de communication et d&apos;appropriation communautaire et utilise les outils developes.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI, les DRSP et les DS pour assurer un engagement communautaire efficace  (Categorie 5 -Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI, les DRSP et les DS pour assurer un engagement communautaire efficace  (Categorie 5 -Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La revue du PEV volet communication est finalis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le developpement de la Demande de la vaccination dans l&apos;encadrement du niveau central et d&#xE9;centralis&#xE9;, dans le developpement et la mise en oeuvre des directives et procedures en communication pour la vaccination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Nombre de Plateformes, d&apos;OSC et de Radios Communautaires suivies et encadrees</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les Organisations de la Societe Civile ainsi que les Radios Communautaires dans la qualite des interventions au profit des communautes, en vaccination (Categorie 5 - Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les Organisations de la Societe Civile ainsi que les Radios Communautaires dans la qualite des interventions au profit des communautes, en vaccination (Categorie 5 - Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation of the final implementation results of the DRS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data Review System">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data Review System">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identification of participants for logistics training</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Recruit, identify and advocate for the participation of at least 25 EPI agents in logistics training">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data review team meetings conducted monthly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the functionality of data review team at national level">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Supportive supervision visits conducted in one region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.1.b. Immunization
funding sensitization
workshops for
National Assembly
and key stakeholders
completed
2.2.b. Secured buy-in
from National
Assembly &amp;
Presidency to
commence process
for First line Charge
for Vaccines
3.1.c. Funds
released for 2021 Q1
&amp; Q2 Vaccines
4. Roadmap to
firstline charge
advocacy concluded</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial
commitments in Nigeria&apos;s Gavi
transition plan (national &amp; state
level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial
commitments in Nigeria&apos;s Gavi
transition plan (national &amp; state
level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.1.b. Immunization funding sensitization workshops for National Assembly and key stakeholders completed
2.2.b. Secured buy-in from National Assembly &amp; Presidency to commence process for First line Charge for Vaccines
3.1.c. Funds released for 2021 Q1 &amp; Q2 Vaccines
4. Roadmap to firstline charge advocacy concluded.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial commitments in Nigeria&apos;s Gavi transition plan (national &amp; state level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Evidence driven and efficiently coordinated campaigns and introductions
2. Data collected, collated, reviewed and triangulated before, during and after campaigns. -</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for supplemental immunisation activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Pilot project plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the pilot implementation of RoverInk in one (1) district to facilitate data collection">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial management procedures document submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The finance specialist recruited.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% improvement in the proportion of LGAs having  &gt;80% children appropriately immunized for age in NERRIC Focus states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% improvement in the proportion of LGAs having &gt;80% children appropriately immunized for age in NERRIC Focus states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Physical stock counting (PSC) exercise completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="10. Physical Stock Counting Exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recruitment of TA to support 3 Hub operationalisation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recruitment completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial management strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NPHCDA and SPHCDA finance staff from 6 prioriy states trained in HACT modalities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finance personnel from the 18 priorities are trained in HACT modality and fiduciary risk control</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Activit&#xE9;s retenues dans la JSP pour l&apos;an 1 &#xE9;valu&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft du PDS 2022-2026 disponible;
Draft avanc&#xE9; du PPAc 2022-2026 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft du PDS 2022-2026 disponible; Draft avanc&#xE9; du PPAc 2022-2026 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial updates on grants utilisation in line with established standards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide programme support on financial management">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide programme support on financial management">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 50% of recommendation of HRH assessment implemented in selected states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. HRS assessment implemented in 2 states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) All labs have applied for WHO certification 2)  Surveillance system revisions in place with standardized weekly epidemiology reports 3)Laboratroy information management system optimize with routine harmonizations with epi data 4) At least 2 outbreak investigated with reports completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2)  1 year Epidemiologist consultant to develop and refine protocols for surveillance, including  case investigation and classification and outbreak response for measles and yellow fever,  and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2)  1 year Epidemiologist consultant to develop and refine protocols for surveillance, including  case investigation and classification and outbreak response for measles and yellow fever,  and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Lab training completed for 14 national staff 2) Epidemiologist consultant hired 3) Lab information consutlant hired 4) Outbreak response plans updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2) 1 year Epidemiologist consultant to develop and refine protocols for surveillance, including case investigation and classification and outbreak response for measles and yellow fever, and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) All labs have applied for WHO certification 2) Surveillance system revisions in place with standardized weekly epidemiology reports 3)Laboratroy information management system optimize with routine harmonizations with epi data 4) At least 2 outbreak investigated with reports completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2) 1 year Epidemiologist consultant to develop and refine protocols for surveillance, including case investigation and classification and outbreak response for measles and yellow fever, and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- Assessment of EOCs conducted (1st step towards standardization)
- Findings and recommendations on how to ensure the EOCs are leveraged for health system strengthening (SERICC, SEMCHIC, etc) presented to the Core Group and NCDC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the design and implementation of an approach to promote the integration and optimal functionality of Polio EOCs and Public EOCs to support SERICCs, SEMCHICs and other PHC operations across states
- Define standards for PH EOC
- Assess all EOCs including polio EOCs for standardization
- Support harmonization and integration of all PH and polio EOCs
- Support standardization of all PH EOCs across Nigeria
- Design framework for integrated functionality of EOCs, SERICC, SEMCHIC and other PHC operations in the state">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#NAME?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the design and implementation of an approach to promote the integration and optimal functionality of Polio EOCs and Public EOCs to support SERICCs, SEMCHICs and other PHC operations across states
- Define standards for PH EOC
- Assess all EOCs including polio EOCs for standardization
- Support harmonization and integration of all PH and polio EOCs
- Support standardization of all PH EOCs across Nigeria
- Design framework for integrated functionality of EOCs, SERICC, SEMCHIC and other PHC operations in the state">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Guidelines for integrating RI in SIA interventions developed
 2. Protocol for COVID-19 impact assessment finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Development of training and operational manuals for new vaccine introduction (IPV2, Rota, HPV). 
 2. Develop a protocol for the conduct COVID-19 vaccine introduction impact assessment. 
 3.Develop regular feedback on updates of VPD surveillance 
 4. Develop an integrated strategies for using SIAs to improve Routine Immunisation
 5. Monitor impact of vaccines introduced and scaled up (measles, yellow fever, meningitis etc)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Operational manuals for IPV2, Rota, COVID-19 developed.
  2. Concept note for COVID-19 Impact Assemment.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Development of training and operational manuals for new vaccine introduction (IPV2, Rota, HPV). 
 2. Develop a protocol for the conduct COVID-19 vaccine introduction impact assessment. 
 3.Develop regular feedback on updates of VPD surveillance 
 4. Develop an integrated strategies for using SIAs to improve Routine Immunisation
 5. Monitor impact of vaccines introduced and scaled up (measles, yellow fever, meningitis etc)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EVM composite score of 80%
2. Improvement in the level of cIP implementation by 70%.
3. A report on assessment of status of scaling up of Push plus (targeted at least &gt;50% of the states implementing push plus)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation and monitoring of EVM, cIPs and ISC2 recommendations.
2. Provide technical support for system re-design and CCEOP implementation. 3. Support NLWG to strenghen capacity and coordination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation and monitoring of EVM, cIPs and ISC2 recommendations.
2. Provide technical support for system re-design and CCEOP implementation. 3. Support NLWG to strenghen capacity and coordination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Data Analysis reports on RISS, DHIS2

2) updated OIRIS implementation dashboards

3) RI-LQAS data reports</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Ensure that the Data Management Team of NERICC are technically guided to provide data management and analysis
2. Support the development and implementation of operational plans to meet objectives of the of the Data Quality Improvement Plans (DQIP)
3. Provide technical support in the review and analysis of RI Supportive Supervision, RI-LQAS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Ensure that the Data Management Team of NERICC are technically guided to provide data management and analysis
2. Support the development and implementation of operational plans to meet objectives of the of the Data Quality Improvement Plans (DQIP)
3. Provide technical support in the review and analysis of RI Supportive Supervision, RI-LQAS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 80% of States with Penta3 coverage of 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support, coordination and partnership for the implementation of NSIPSS focusing on contributions to strategic technical decisions of the Technical Management Team of:
- NERICC (RED/OIRIS), 
- New Vaccine Introduction
- Accelerated Disease Control interventions, and 
- NGI TAG
- VPD surveillance, 
aiming at strengthening and improving routine immunisation and PHC

2. Support the coordination and conduct of JA and other partnership reviews">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support, coordination and partnership for the implementation of NSIPSS focusing on contributions to strategic technical decisions of the Technical Management Team of:
- NERICC (RED/OIRIS), 
- New Vaccine Introduction
- Accelerated Disease Control interventions, and 
- NGI TAG
- VPD surveillance, 
aiming at strengthening and improving routine immunisation and PHC

2. Support the coordination and conduct of JA and other partnership reviews">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Independent Consultants (PEF) : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Update Gavi team on introduction and campaign planning and implementation. 
2.Provide written reports on work completed to Gavi Secretariat on a monthly basis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Support the implementation of Gavi?s strategy of support to the Government of Nigeria (GoN) for strengthening immunisation and primary health care. 
2.	Provide technical support to the Federal Government of Nigeria (FGoN) through the National Primary Health Care Development Agency (NPHCDA) and state governments to assess the current needs in the primary health care system including immunisation and develop strategies to increase immunization coverage with special focus on reaching zero-dose children.  
3.	Participate in strategic meetings of the National Emergency Routine Immunization Coordination Centre (NERICC) and other technical working groups such as the Non-Polio SIA team (NPSIA) in line with the operationalization of the National Strategy for Immunization and PHC System Strategy (NSIPSS) and serve as a liaison to ensure linkage between routine immunisation, vaccine introduction and campaigns.
4.	Support the GoN to respond effectively and efficiently to any emerging vaccine preventable disease threat (this may include epi analyses and coordination of activities between GoN, partners and NGOs).
5.	Assist NPHCDA with developing proposals for Gavi support and addressing issues raised by the IRC.
6.	Monitor the implementation of wastage study findings on behalf of Gavi and represent Gavi at related critical meetings with the National Logistics Working Group (NLWG)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Support the implementation of Gavi?s strategy of support to the Government of Nigeria (GoN) for strengthening immunisation and primary health care. 
2.	Provide technical support to the Federal Government of Nigeria (FGoN) through the National Primary Health Care Development Agency (NPHCDA) and state governments to assess the current needs in the primary health care system including immunisation and develop strategies to increase immunization coverage with special focus on reaching zero-dose children.  
3.	Participate in strategic meetings of the National Emergency Routine Immunization Coordination Centre (NERICC) and other technical working groups such as the Non-Polio SIA team (NPSIA) in line with the operationalization of the National Strategy for Immunization and PHC System Strategy (NSIPSS) and serve as a liaison to ensure linkage between routine immunisation, vaccine introduction and campaigns.
4.	Support the GoN to respond effectively and efficiently to any emerging vaccine preventable disease threat (this may include epi analyses and coordination of activities between GoN, partners and NGOs).
5.	Assist NPHCDA with developing proposals for Gavi support and addressing issues raised by the IRC.
6.	Monitor the implementation of wastage study findings on behalf of Gavi and represent Gavi at related critical meetings with the National Logistics Working Group (NLWG)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">? Harmonized HSS workplan developed ? Quarterly report on implementation status of NERICC workplan developed and shared with Gavi ? Joint Appraisal Review successfully conducted ? High-level review of Accountability Framework results conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM ? Provide critical technical support (as may be required) on all Gavi-funded interventions ? Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS ? Monitor and track progress on the accountability framework ? Provide support to the NVSTT in the development of requisite documents for new vaccines introductions ? Support the NPSIA team in the development and submission of required documents for planned campaigns ? Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM ? Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required ? Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks ? Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings ? Report proceedings of PMT meetings to GAVI ? Ensure proper storage and management of CCEOP documents and data ? Support development and timely submission of relevant data and documents from PMT to Gavi as may be required ? Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks ? Support the PMT to identify sites ready for CCE installation ? Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions ? Monitor and report the progress of Key performance indicators ? Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors ? Work with the PMT to ensure commitments from the states to the project ? Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE ? Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE ? Support PMT to monitor and track CCE distribution, installation and commissioning ? Lead the development of templates for tracking various Key performance indicators ? Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Financial reports of utilization of Gavi funds across Gavi-supported programmes, including state budget, submitted every quarter (or as required)
?	Report on execution of activities and funds including the absorption rate per budget item
?	Request for reprogramming or reallocation submitted to Gavi in a timely manner
?	Timely submission of request for funding to WHO and UNICEF
?	Harmonization of HSS and NERICC workplans conducted 
?	Required budgets for NERICC, NLWG, Non-Polio SIAs and other programmes developed, agreed with WHO and UNICEF finance teams and submitted on time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Proactively monitor the execution of activities and utilization of Gavi funds by the RI and SIA teams, for NPHCDA and partners and provide weekly reports to the Gavi SCM and NPHCDA leadership
?	Support NERICC and other teams (where necessary) in the development of appropriate workplans and budgets for Gavi-funded activities
?	Track utilization of Gavi funds for the intended purposes and flag any potential issues related to execution of Gavi funds to Gavi teams.
?	Provide strategic efforts towards harmonisation, integration, when feasible, and ensure complementarities across the multiple programmes and/or projects funded by Gavi and by other partners.
?	Support identification and implementation of synergistic approaches that will deliver maximum impact and value for money in the roll-out of health system strengthening plans
?	Strengthen cross-communication and collaboration among Gavi-funded organizations (WHO, UNICEF, US-CDC, etc)
?	Provide systematic support in optimization of planned activities to eliminate/minimize wastage of resources
?	Proactively flag any delays in implementation or release of funds and provide options to address the bottlenecks and improve the absorption of funds.
?	Support NERICC and the NPSIA teams to report on execution of activities, Gavi grants and fund utilization and absorption to the Core Group, the Inter Agency Coordinating Committee (ICC) and the Gavi Secretariat.
?	Support the development of state-specific plans for improving RI and PHC, in line with the NSIPSS as well as support states to develop LGA-specific plans to improve RI and PHCMonthly reporting to Gavi and proactive reporting on specific issues and/or identified risks">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Harmonized HSS workplan developed
?	Quarterly report on implementation status of NERICC workplan developed and shared with Gavi
?	Joint Appraisal Review successfully conducted
?	High-level review of Accountability Framework results conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM 
?	Provide critical technical support (as may be required) on all Gavi-funded interventions 
?	Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS 
?	Monitor and track progress on the accountability framework 
?	Provide support to the NVSTT in the development of requisite documents for new vaccines introductions 
?	Support the NPSIA team in the development and submission of required documents for planned campaigns 
?	Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM 
?	Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required 
?	Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks
?	Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings
?	Report proceedings of PMT meetings to GAVI 
?	Ensure proper storage and management of CCEOP documents and data 
?	Support development and timely submission of relevant data and documents from PMT to Gavi as may be required 
?	Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks
?	Support the PMT to identify sites ready for CCE installation
?	Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions 
?	Monitor and report the progress of Key performance indicators
?	Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors 
?	Work with the PMT to ensure commitments from the states to the project 
?	Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE
?	Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE
?	Support PMT to monitor and track CCE distribution, installation and commissioning   
?	Lead the development of templates for tracking various Key performance indicators  
?	Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM 
?	Provide critical technical support (as may be required) on all Gavi-funded interventions 
?	Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS 
?	Monitor and track progress on the accountability framework 
?	Provide support to the NVSTT in the development of requisite documents for new vaccines introductions 
?	Support the NPSIA team in the development and submission of required documents for planned campaigns 
?	Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM 
?	Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required 
?	Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks
?	Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings
?	Report proceedings of PMT meetings to GAVI 
?	Ensure proper storage and management of CCEOP documents and data 
?	Support development and timely submission of relevant data and documents from PMT to Gavi as may be required 
?	Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks
?	Support the PMT to identify sites ready for CCE installation
?	Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions 
?	Monitor and report the progress of Key performance indicators
?	Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors 
?	Work with the PMT to ensure commitments from the states to the project 
?	Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE
?	Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE
?	Support PMT to monitor and track CCE distribution, installation and commissioning   
?	Lead the development of templates for tracking various Key performance indicators  
?	Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;sultats d&apos;au moins une (1) recherche op&#xE9;rationnelle publi&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 50% of recommendation of HRH assessment implemented in selected states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. HRH assessment protocol developed 2. HRS assessment implemented in 2 states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Training materials developed and used by 90% of trained personnel for SIAs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation of accelerated disease control activities focusing on Measles, Yellow Fever and MNTE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation of accelerated disease control activities focusing on Measles, Yellow Fever and MNTE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Report on SMS systems server evaluation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical and operational support for the conduct of quarterly LQAs and Routine Data Analysis at NERICC.
2 .Support Real time AEFI reporting
3. Conduct JRF estimates for states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical and operational support for the conduct of quarterly LQAs and Routine Data Analysis at NERICC.
2 .Support Real time AEFI reporting
3. Conduct JRF estimates for states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft rapport d&apos;&#xE9;valuation disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance techniques pour l&apos;&#xE9;valuation finale de la feuille de route DHIS2 Niger 2019-2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance techniques pour l&apos;&#xE9;valuation finale de la feuille de route DHIS2 Niger 2019-2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts r&#xE9;alisent des revues de validation et d&apos;analyse des donn&#xE9;es de la vaccination  prenant en compte la triangulation avec les donn&#xE9;es de gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des agents communautaires  menent des activites de suivi communautaire des enfants de 0-23 mois et de declaration des naissances dans les 33 districts sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la  mise en place des registres communautaires pour le suivi communuataire de la vaccination et  autres activites de sante ainsi que la declaration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la  mise en place des registres communautaires pour le suivi communuataire de la vaccination et  autres activites de sante ainsi que la declaration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Action plans to implement recommendations of MSD and EPI reviews developed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support in the national level leadership, management and coordination of the immunization program 
 1.1. Contribute to the national level planning, management and coordination meetings including TWGs, ICC, Core group, NERICC, NPSIAs, etc
 1.2. Participate in the regular monitoring and evaluation of the immunization program including OIRIS visits, review meetings, new vaccines introductions, SIAs monitoring, MSD, etc">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI reviews and Multi-Stakeholder Dialogue are well managed ensuring availability of relevant data to track progress.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support in the national level leadership, management and coordination of the immunization program 
 1.1. Contribute to the national level planning, management and coordination meetings including TWGs, ICC, Core group, NERICC, NPSIAs, etc
 1.2. Participate in the regular monitoring and evaluation of the immunization program including OIRIS visits, review meetings, new vaccines introductions, SIAs monitoring, MSD, etc">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity assessment performed in identified urban slum areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support in the conduct of the immunization coverage survey, equity assessment and identification of missed communities 
 2.1 Support the conduct of MICS/NICS
 2.2 Support equity assessment in priority areas 
 2.3 support poor performing LGAs in developing an integrated micro plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National routine immunization coverage survey Implemented-MICS/NICS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support in the conduct of the immunization coverage survey, equity assessment and identification of missed communities 
 2.1 Support the conduct of MICS/NICS
 2.2 Support equity assessment in priority areas 
 2.3 support poor performing LGAs in developing an integrated micro plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integration microplanning guides and tools adapted/developed based on the national REW/RED guide</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. support priority states, wards and LGAs to provide integrated EPI and PHC services
 3.1 Develop an integration guide and tools
 3.2 Support the microplanning process
 3.3 Support integrated services.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. support priority states, wards and LGAs to provide integrated EPI and PHC services
 3.1 Develop an integration guide and tools
 3.2 Support the microplanning process
 3.3 Support integrated services.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts prioritaires disposent d&apos;un microplan PEV ax&#xE9; sur l&apos;&#xE9;quit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 19 ECD des 33 districts prioritaires dans l&apos;&#xE9;laboration des micro plans PEV sur la base du guide ACD/CEA et dans la mise en ?uvre des paquets d&apos;intervention dans les districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% districts prioritaires ont mis en ?uvre leur microplan PEV ACD/CEA et les paquets d&apos;intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 19 ECD des 33 districts prioritaires dans l&apos;&#xE9;laboration des micro plans PEV sur la base du guide ACD/CEA et dans la mise en ?uvre des paquets d&apos;intervention dans les districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les documents du dialogue multipartite sont en cours de collecte</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et la DEP dans l&apos;organisation du Dialogue Multipartite avec Gavi en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un dialogue multipartite est organis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et la DEP dans l&apos;organisation du Dialogue Multipartite avec Gavi en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1 Capacity of health workers built on conduct of integrated RI intenfication to missed communities ( Uban slums,under servce communities and zero dose children ). 1.2 Integrated routine immunization intensification conducted in the identified missed communites including under served communities in the identified LGAs. 1.3 OIRIS activity conducted and supervised in priority states/LGAs/HFs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical Support to NERICC and states on ithe development of annual work plan,OIRIS implementation strategy and new vaccines introduction. 1.1 Provide technical support to Gavi supported eight (8) states on identification and mapping of zero dose children, missed communities and implementation of strategies to reduce number of zero dose and reached missed children. 1.2 Provide support to priority states on the development of REW microplans and implementation of RI intensification in uban slums and missed/underserve communities.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro,,Abalak, Bermo,Malbaza,Tessaoua, G. Roumdji,Madaoua, Tahoua D&#xE9;partement,,Bouza,)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro,,Abalak, Bermo,Malbaza,Tessaoua, G. Roumdji,Madaoua, Tahoua D&#xE9;partement,,Bouza,)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40% des districts urbains et semi-urbains identif&#xE9;s ont mis en oeuvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les 6 districts prioritaires RSS3 (B.Konni, Maradi Ville, Niamey5, Niamey3,Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% des districts urbains et semi-urbains identif&#xE9;s ont mis en oeuvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les 6 districts prioritaires RSS3 (B.Konni, Maradi Ville, Niamey5, Niamey3,Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1 NERIC and states supported in the development of annual work plan on identification and mapping of zero dose children, 1.2. Barriers of missed communities to access immunisation services identified and prioritised 1.3 .REW micro-plan developed and suitable approached to reach missed communities identified and endorsed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical Support to NERICC and states on ithe development of annual work plan,OIRIS implementation strategy and new vaccines introduction. 1.1 Provide technical support to Gavi supported eight (8) states on identification and mapping of zero dose children, missed communities and implementation of strategies to reduce number of zero dose and reached missed children. 1.2 Provide support to priority states on the development of REW microplans and implementation of RI intensification in uban slums and missed/underserve communities.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La strat&#xE9;gie de vaccination en zone d&apos;ins&#xE9;curit&#xE9; est &#xE9;labor&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour l&apos;&#xE9;laboration de la strategie de vaccination dans les 8 DS situ&#xE9;s en zone d?ins&#xE9;curit&#xE9; (Abala, Main&#xE9; soroa, Bankilar&#xE9;, Bosso, Tera, Ayerou, Tillia, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les documents pour l&apos;&#xE9;laboration de la strat&#xE9;gie sont collect&#xE9;s et analys&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour l&apos;&#xE9;laboration de la strategie de vaccination dans les 8 DS situ&#xE9;s en zone d?ins&#xE9;curit&#xE9; (Abala, Main&#xE9; soroa, Bankilar&#xE9;, Bosso, Tera, Ayerou, Tillia, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All priority LGAs supported in developing annual workplan , identification of missed communities, zero dose children and implementation strategy,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to Lagos State in all LGAs in the NSIPSS implmentation and improving RI coverage, identification of missed communities,urban slums, zero dose children, conducting successful NPSIAs, and introducition of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The LGAs are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to Lagos State in all LGAs in the NSIPSS implmentation and improving RI coverage, identification of missed communities,urban slums, zero dose children, conducting successful NPSIAs, and introducition of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All priority states supported in developing annual workplan , identification of missed communities, zero dose children and implementation strategy,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, identification of missed communities and zero dose children,conducting successful NPSIAs, and introduction of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The states are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, identification of missed communities and zero dose children,conducting successful NPSIAs, and introduction of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils et modules DQS r&#xE9;vis&#xE9;s
50% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. DHIS2 Server optimization analysis done
d</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct Data Quality Analysis, Reviews and Feedback to monitor the level of improvement of Data Quality in line with the DQIP. 
 2. Conduct HMIS/DHIS2 server utilitity and response gaps and make recommendations for improvement 
 3. Develop guidelines for the implementation and scale up of the RI SMS projects and eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Developed platform for electronic immunisation registry</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct Data Quality Analysis, Reviews and Feedback to monitor the level of improvement of Data Quality in line with the DQIP. 
 2. Conduct HMIS/DHIS2 server utilitity and response gaps and make recommendations for improvement 
 3. Develop guidelines for the implementation and scale up of the RI SMS projects and eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation des reunions mensuelles d&apos;analyse et de triangulation des donn&#xE9;es de vaccination dans les 33 districts prioritaires; trimestrielle au niveau regional et central y compris la production des bulletins trimestriels avec feedback (plan de resolution de probl&#xE8;me)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data guidance / SOP developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation des reunions mensuelles d&apos;analyse et de triangulation des donn&#xE9;es de vaccination dans les 33 districts prioritaires; trimestrielle au niveau regional et central y compris la production des bulletins trimestriels avec feedback (plan de resolution de probl&#xE8;me)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 Protocoles de recherche disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de 02 recherches op&#xE9;rationnelles sur l&apos;introduction du vaccin contre la COVID-19 et son impact sur le programme de vaccination (Enqu&#xEA;te Innocuit&#xE9; - Etude Cas-temoin)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documents des r&#xE9;sultats de recherche disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de 02 recherches op&#xE9;rationnelles sur l&apos;introduction du vaccin contre la COVID-19 et son impact sur le programme de vaccination (Enqu&#xEA;te Innocuit&#xE9; - Etude Cas-temoin)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 30% des activit&#xE9;s cibl&#xE9;es pour 2021 dans le PAQD sont mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre et le suivi des activit&#xE9;s du plan strat&#xE9;gique d&apos;am&#xE9;lioration des donn&#xE9;es (PAQD 2020-2022)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 60% des activit&#xE9;s cibl&#xE9;es pour 2021 dans le PAQD sont mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre et le suivi des activit&#xE9;s du plan strat&#xE9;gique d&apos;am&#xE9;lioration des donn&#xE9;es (PAQD 2020-2022)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All NERICC data team trained on routine data analysis template</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop, complie and share monthly RI, Supportive Supervision and AEFI feedback.
 Develop and implement dashboards to monitor quality of preparedness and outputs of service delivery strategies for routine immunisation
 Identify and develop data management related protocols for PAPA LQAS, MICS/NICS, EVMA etc.
 Compile data elements for the eJRF; and Joint Appraisals">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine Feedback on RISS, AEFI, RI services updated and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop, complie and share monthly RI, Supportive Supervision and AEFI feedback.
 Develop and implement dashboards to monitor quality of preparedness and outputs of service delivery strategies for routine immunisation
 Identify and develop data management related protocols for PAPA LQAS, MICS/NICS, EVMA etc.
 Compile data elements for the eJRF; and Joint Appraisals">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils et modules DQS r&#xE9;vis&#xE9;s 50% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30 agents des niveaux central et r&#xE9;gional sont capacit&#xE9;s sur la m&#xE9;thodologie d?&#xE9;laboration des projections</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Former 14 agents du niveau central et 16 soit 2 cadres par region provenant des 08 regions sur la m&#xE9;thodologie d?&#xE9;laboration des projections (y compris les cibles pour la vaccination) en lien avec la sant&#xE9; par l&apos;Institut National de la Statistique">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La note conceptuelle de formation est &#xE9;labor&#xE9;e, les outils et mat&#xE9;riels divers de la formation sont developp&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Former 14 agents du niveau central et 16 soit 2 cadres par region provenant des 08 regions sur la m&#xE9;thodologie d?&#xE9;laboration des projections (y compris les cibles pour la vaccination) en lien avec la sant&#xE9; par l&apos;Institut National de la Statistique">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All states are disbursing BHCPF funds in line with operational manual</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">WBG uses its convening power to regularly interact with parliamentarians, Ministry of FInance, Budget and National Planning to ensure that the GON maintains its commitment to PHC, including immunization, through the BHCPF.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Mobilizing more resources for primary health care and the immunisation programme, including vaccine procurement through coordinated high-level advocacy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Trainings on BHCPF at the state level and ongoing technical support to ensure and track state readiness through the PHC readiness tracker.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.) Vaccine financing plan to transition from loans developed and agreed with stakeholders. 
 2.) Scenarios of vaccine financing in the medium term (based on the short-to-medium term economic outlook) developed and discussed with stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis; including the analysis of performance against vaccine financing targets in the Accountability Framework">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccine financing plan developed and agreed with stakeholders on an annual basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis; including the analysis of performance against vaccine financing targets in the Accountability Framework">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Report on performance of health finance indicators of the acountability framework developed
 2. Progress report on strategic vaccine financing developed and discussed with stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Framework for health financing strategy developed based on analytical work</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Key analytics including the HFSA protocol completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Antimicrobial susceptibility testing of CSF specimens complete; whole genome sequencing of CSF specimens complete</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits to at least 5 sites; Complete analysis &gt;90% of specimens collected in 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens complete</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of 2 national and &gt;4 regional labs on detection of bacterial meningitis using the latest effective technology; Implement in-country quality programs to ensure lab proficiency. Complete analysis &gt;90% of specimens collected between Jan-Aug 2020;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; and generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preperation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preperation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits at least 5 sites; Complete analysis &gt;90% of specimens collected in 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of national and 8 state referal labs on detection of bacterial meningitis using the latest effective technology; Implement in-country quality programs to ensure lab testing proficiency within the lab network; Complete analysis of &gt;90% of specimens collected between Jan-Aug 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate lab testing flows for meningitis within national laboratory network; 

Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at the national lab and at least 1 regional lab that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of data management and specimen transport system efficiency and integration status, roll-out of updated data management and specimen tracking system nationwide</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Generation of routine meningitis surveillance performance feedback summaries to guide national monitoring and evaluation, with a target of &gt;90% of participating districts reporting data monthly and &gt;80% of suspected meningitis cases have a specimen collected</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate specimen management and lab testing flows for meningitis within national laboratory network; 

Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at national and state labs (8 priority state labs at least) that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete epidemic preparedness plan and Attend the Annual Meeting of Meningitis Belt countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of data management system efficiency and integration status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assessment of materials conducted and tools adapted as needed for in-country needs. Materials included in planning for phased MCV2 introduction.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging findings from a targeted EPI program assessment in 3 states planned for January 2019, we will provide technical support for the planned introduction of MCV2 in Nigeria in 2019. This will include operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and roll-out of training materials for 2YL, with emphasis on use of MCV2 as an opportunity to catch-up children on vaccinations that were missed during the first year of life; communications messaging to increase awareness and demand for MCV2">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; and generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and stregthen case-based surveillance for VPD program monitoring, early detection of meningitis epidemics and equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens by PCR and culture, and reinforce quality assurance programs to ensure laboratory proficiency for the molecular detection at the national level, and bacterial culture proficiency subnationally; 2) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2) to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Conducted training and mentoring of NPHCDA staff on vaccines and financial forecasting
?	2022 State-specific and national vaccines and devices forecast for 36 states + FCT with other health commodities concluded
?	2021 ? 2024 Vaccines Finance outlook documents developed
?	2022 vaccine procurement schedule submitted and reviewed with MoBP and MoF
?	Funds released for Q1 &amp; Q2 2021 vaccines 
?	First line charge preliminary analysis conducted, developed and disseminated advocacy tools</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the implementation of the financial commitment as laid out in the transition plan">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Evidence driven
and efficiently
coordinated
campaigns and
introductions
2. Data collected,
collated, reviewed and triangulated
before, during and
after campaigns.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for
supplemental immunisation
activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for
supplemental immunisation
activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Funds released for Q3 &amp; Q4 2021 Vaccines procurement 
?	All planned immunisation funding sensitization workshops for National Assembly, MOPB and MoF completed.
?	Adequate budgetary allocation for vaccines in the approved 2022 FGoN budget
?	All high-level meetings /events for the 2022 Gavi High Level visit confirmed
?	Annual review of 2021 vaccines and device forecast</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the implementation of the financial commitment as laid out in the transition plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Finalize and distribute surveillance and outbreak response guidance 
2) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever
3) Support VPD data transition to SORMASacross all states, with at least one quarterly review completed
4) Draft SOPs for measles and YF outbreak investigation and response</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To reduce the number of outbreaks in the country, it is critical that surveillance and lab testing capacity is optimal. The US CDC will continue to support NCDC in the development of a national disease surveillance system, lab network, outbreak response plans, and diagnostic testing for measles, rubella and yellow fever to include: 1) Conduct lab training for the testing of measles, rubella, and yellow fever 2) Finalize surveillance and outbreak response guidance 3) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever, 4) Support implementation of SORMAS surveillance system 5) Support outbreak investigations with NCDC staff by training state and local level staff 6) Introduce measles rapid diagnostic testing">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) YF lab training scheduled
2) All states transitioned to SORMAS; post transition evaluations completed
3) National surveillance and OB investigation and response training for measles and YF completed
4) Draft guidelines and SOPs for measles RDT implementation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To reduce the number of outbreaks in the country, it is critical that surveillance and lab testing capacity is optimal. The US CDC will continue to support NCDC in the development of a national disease surveillance system, lab network, outbreak response plans, and diagnostic testing for measles, rubella and yellow fever to include: 1) Conduct lab training for the testing of measles, rubella, and yellow fever 2) Finalize surveillance and outbreak response guidance 3) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever, 4) Support implementation of SORMAS surveillance system 5) Support outbreak investigations with NCDC staff by training state and local level staff 6) Introduce measles rapid diagnostic testing">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of identified NPHCDA and SPHCDA finance staff trained on HACT and fiduciary risk control 50% Programme Monitoring Visits completion rate (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of identified NPHCDA and SPHCDA finance staff trained on HACT and fiduciary risk control
50%  Programme Monitoring Visits  completion rate  (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile.                  Technical support for strategic  management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile.                  Technical support for strategic  management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">25% of identified NPHCDA and SPHCDA finance staff from prioriy states trained on HACT and fudiciary risk control 80% Programme Monitoring Visits (Financial) completion rate (anualized) in NERICC states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 50% des activit&#xE9;s prevues dans le PAA du PEV et microplans des districts sont r&#xE9;alis&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre, le suivi et l&apos;&#xE9;valuation des plans programmatiques du PEV y compris l&apos;appui &#xE0; l&apos;organisation de deux revues (&#xE0; mi parcours et annuellle) du PAA du PEV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TDRs et la note conceptuelle des revues PAA sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre, le suivi et l&apos;&#xE9;valuation des plans programmatiques du PEV y compris l&apos;appui &#xE0; l&apos;organisation de deux revues (&#xE0; mi parcours et annuellle) du PAA du PEV">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des activit&#xE9;s mises en ?uvre et renseign&#xE9;es &#xE0; travers le dashboard</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en place d&apos;un syst&#xE8;me de monitoring des activit&#xE9;s de vaccination des populations sp&#xE9;cifiques et des enfants zero doses et insuffisement vaccin&#xE9;s dans les 14 districts prioritaires des 04 regions (Agadez, Dosso, Tillabery et Zinder)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un dashboard pour le monitoring et &#xE9;valuation des activit&#xE9;s de vaccination &#xE9;labor&#xE9; et diffus&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en place d&apos;un syst&#xE8;me de monitoring des activit&#xE9;s de vaccination des populations sp&#xE9;cifiques et des enfants zero doses et insuffisement vaccin&#xE9;s dans les 14 districts prioritaires des 04 regions (Agadez, Dosso, Tillabery et Zinder)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport pour la revue du PEV 2021 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation de la revue externe du PEV en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recrutement des consultants (international et national) pour appuyer la revue externe du PEV finalis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation de la revue externe du PEV en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.PSC RFQs and vendors selection finalised, PSC data and reports available.2. Mock audit exercise conducted 3.Forecast for 2021 reviewed and adjusted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Facilitate conduct of nationwide physical stock count exercise, supporting the entrenchment of quarterly PSC and Conduct of annual state specific vaccines and devices forecasting exercise in line with revised coverage and targets; support conduct of vaccine audit exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">72 districts utilisent l&apos;Outil &quot;Stock report&quot; pour la visibilit&#xE9; du niveau des stocks des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 r&#xE9;gions tiennent des r&#xE9;unions mensuelles d&apos;analyse des donn&#xE9;es de gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du plan d&apos;am&#xE9;lioration de la GEV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les mesures de d&#xE9;douanement des &#xE9;quipements des ann&#xE9;es 3 et 4 sont mises en place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et les 8 r&#xE9;gions dans la mise en ?uvre du CCEOP, et le suivi de la gestion des &#xE9;quipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les plans de d&#xE9;ploiement operationnels du CCEOP 2 et de l&apos;ann&#xE9;e 5 du CCEOP 1 sont &#xE9;labor&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et les 8 r&#xE9;gions dans la mise en ?uvre du CCEOP, et le suivi de la gestion des &#xE9;quipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;&#xE9;tude de faisabilit&#xE9; d&apos;eLMIS est r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la Direction des Immunisations dans l&apos;am&#xE9;lioration de la disponibiit&#xE9;, la qualit&#xE9; et l&apos;utilisation des donn&#xE9;es de gestion de l&apos;information logistique (vaccins et &#xE9;quipements de la chaine du froid)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les ressources humaines dedi&#xE9;es &#xE0; la cha&#xEE;ne d&apos;approvisionnement sont form&#xE9;es dans l&apos;utilisation du tableau de bord de la gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la Direction des Immunisations dans l&apos;am&#xE9;lioration de la disponibiit&#xE9;, la qualit&#xE9; et l&apos;utilisation des donn&#xE9;es de gestion de l&apos;information logistique (vaccins et &#xE9;quipements de la chaine du froid)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des r&#xE9;gions organisent des reunions d&apos;analyse des donn&#xE9;es de gestion de vaccins et des ECF</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 8 r&#xE9;gions et 72 districts dans la mise en ?uvre du CCEOP, le suivi de la gestion des &#xE9;quipements de la chaine de froid et des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un inventaire des ECF est mis &#xE0; jour</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 8 r&#xE9;gions et 72 districts dans la mise en ?uvre du CCEOP, le suivi de la gestion des &#xE9;quipements de la chaine de froid et des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the sites targeted for CCEOP have validated Operational Deployment Plan (ODP)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor the CCEOP implementation, track performance of maintainance units and facilitate development and implementation of maintainance and rehabilitation plans">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project management team estalished and workplan available. ToR for Cold room and infrastructure procurement completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the construction and outfitting of Abuja Mega hub project implementation at National Strategic Cold Store">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project Operational Deployment Plan (ODP) developed for 6,346 CCEs and 30% installation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the deployment of Cold Chain Equipment and implementation of CCEOP project as well as facilitating the inventory management system">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised target coverage, population and other assumptions developed and 2022 forecasting exercise conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Facilitate conduct of nationwide physical stock count exercise, supporting the entrenchment of quarterly PSC and Conduct of annual state specific vaccines and devices forecasting exercise in line with revised coverage and targets; support conduct of vaccine audit exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">iSC roadmap finalized and 2022 annualized NLWG work plan developed and submitted to NPHCDA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalization of 10 year iSC road map following the completion of the iSC policies">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalization of 10 year iSC road map following the completion of the iSC policies">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">eLMIS requirement collection for the country finalised, funding source available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">internal workflows for the hubs developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Action plan for the implementation of vaccine audit exercise available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les TDR du consultant pour la revue externe du PEV composante logistque sont finalis&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% of sites generated for Q2 in zone assesed and reports generated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Faciltate quarterly effective Vaccine Management Assessments for subnational stores (zonal and state); supporting zones and states to develop, implement and monitor cIPs">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Human resource requirement and plan for deployment available including roles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Contract awarded and 40% project works completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the construction and outfitting of Abuja Mega hub project implementation at National Strategic Cold Store">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of national, zonal an state cold stores and 60% of CCEs at LGA and HF level have functional RTM</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination of Remote Temperature Monitoring (RTM) system and facilitate capacity to review and provide regular feedback">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recommendations from the FtV finalised and action plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du plan d&apos;am&#xE9;lioration de la GEV">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training for eLMIS users facilitated in the 100% of the states in the zone</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate rollout of e-LMIS at subnational levels and support monitoring of accuracy, timeliness and completeness of reporting">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strategic planning documentation for Q1 nationwide EVMA and cIP,supported
 and submitted to NLWG</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Faciltate quarterly effective Vaccine Management Assessments for subnational stores (zonal and state); supporting zones and states to develop, implement and monitor cIPs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM Assement completed and submitted to MoH, including
 supporting analysis of VfM and zero-dose considerations (as applicable)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In line with GAVI Immunization Supply Chain Steering Committee (iSC2) mission recommendation, provide Technical Support for the conduct of quarterly targeted and nationwide EVMAs, Development and monitoring of cIPs, facilitating system design activities, and implementation of iSC2 recommendations">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">country&apos;s EVM environment set up reviewed, Site selection conducted and assesment created, assessor refresher orientation conducted. 2 system design assesment completed in targetted states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In line with GAVI Immunization Supply Chain Steering Committee (iSC2) mission recommendation, provide Technical Support for the conduct of quarterly targeted and nationwide EVMAs, Development and monitoring of cIPs, facilitating system design activities, and implementation of iSC2 recommendations">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Logistics plans and NDVP finalsed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging on the CCEOP and 3 Hubs system/Abuja NSCS upgrade, support the capacity requirement estimation and prioritization for readiness towards introduction of new vaccines such as Rota; including the implementation of logistics plan.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical guidance based on the countries experience in the new vaccine (COVID-19) deployment adjusted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging on the CCEOP and 3 Hubs system/Abuja NSCS upgrade, support the capacity requirement estimation and prioritization for readiness towards introduction of new vaccines such as Rota; including the implementation of logistics plan.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of target states have updated CCE management documents
 (e.g. CCE inventory, or Cold Chain Expansion and
 Rehabilitation Plan, CCE maintenance plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor the CCEOP implementation, track performance of maintainance units and facilitate development and implementation of maintainance and rehabilitation plans">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">eLMIS solution selected and developed. Training for the roll out conducted Sites for field test identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunization supply chain annual workplan and budgets including interventions to reach last mile/ zero dose children in place.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the development, implementation, monitoring and evaluation of NLWG strategic priorities and initiatives as detailed in the annualised work plan; Support the strengthening of NLWG and ZLWGs and facilitate the integration of the broader PHC supply chain coordination efforts.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NLWG convened 3 times per week and demonstrated to be meeting regularly in past [6] months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the development, implementation, monitoring and evaluation of NLWG strategic priorities and initiatives as detailed in the annualised work plan; Support the strengthening of NLWG and ZLWGs and facilitate the integration of the broader PHC supply chain coordination efforts.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40% of the action points from the coordination meeting implemented in atleast 50% of the states in the zone</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strenghening of ZLWG/SLWG and facilitate coordination efforts with other relevant fora to achieve supply chain synergy at subnational level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of the planned meeting between ZLWG and SLWGs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strenghening of ZLWG/SLWG and facilitate coordination efforts with other relevant fora to achieve supply chain synergy at subnational level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of states under the zone supported to implement workplan and updated supply chain guidance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical liaisons between the NLWG and SLWGs, within zonal catchment areas, and support alignment and implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunization supply chain annual workplan and budgets including interventions to reach last mile/ zero dose children adapted for zonal and state levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical liaisons between the NLWG and SLWGs, within zonal catchment areas, and support alignment and implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% installation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the deployment of Cold Chain Equipment and implementation of CCEOP project as well as facilitating the inventory management system">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La revue de la composante logistique et chaine d&apos;approvisionnement a finalis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 cadres de la DI ont b&#xE9;n&#xE9;fici&#xE9; d&apos;une formation sur le monitorage pour action selon le mod&#xE8;le de Tanahashi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les ECD des 33 districts prioritaires ont benefici&#xE9; d&apos;une mise &#xE0; niveau sur l&apos;analyse des donn&#xE9;es et le monitorage pour action selon le modele de Tanahashi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts prioritaires et 8 r&#xE9;gions ont r&#xE9;alis&#xE9; le LQAS/DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribuer &#xE0; la mise en ?uvre du LQAS/DQS dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le guide de Microplanificaton 2021 ACD/CEA y compris les outils adapt&#xE9;s sont diffus&#xE9;s dans tous les districts sanitaires (prioritaires et non prioritaires) des 04 regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 80% of Service delivery strategies in the plan Implemented. 2 Introduction of IPV2, Rota and COVID-19 vaccine 
 3.At least one one service delivery approach (PIRI activity) focused on zero dose children and missed communities implemented 
 4.Information on Health worker availability in underserved within 8 GAVI priority States available. 5. MICS/NICS report.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Develop guidelines for the development and monitoring of States RI operational plans 
 2. Assess the quality of REW microplans and its implementation in addressing the burden of zero dose.
 3. Provide support for planning and technical coordination for the introduction of New vaccines as IPV2, Rota, HPV. 
 4. Develop and implement guidlines for the identification of RI human resource gaps and training of RI managers focusing on underserved areas. 
  5. Develop/update technical guidelines for conduct of PAPA/LQAS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Updated Guidelines on PAPA LQAS.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Develop guidelines for the development and monitoring of States RI operational plans 
 2. Assess the quality of REW microplans and its implementation in addressing the burden of zero dose.
 3. Provide support for planning and technical coordination for the introduction of New vaccines as IPV2, Rota, HPV. 
 4. Develop and implement guidlines for the identification of RI human resource gaps and training of RI managers focusing on underserved areas. 
  5. Develop/update technical guidelines for conduct of PAPA/LQAS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) 10% increase in LGAs with penta3 coverage of &gt;80%
 2) 80% of NGI-TAG Disease Working Group meeting held
 3) Annual workplan developed in line with reaching zero dose and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide routine technical support to strengthen partnership, coordination and immunisation programme planning and implemenation at national and sub-national levels focusing on :
  - Development of recovery and catch-up stragegy for routine immunisation
  - strengthening functionality of ICC, NGI-TAG and others to strengthening broader monitoring of Immunisation performance.
  - coordinating and monitoring priority stratgies to reach zero-dose children and unreached communities in the 8 Gavi Focus states and other states
  - supporting the development of a roadmap for improved integration of EPI with other PHC services
  - coordinate the introduction of new vaccine introduction and vaccine specific support including nOPV and related PIE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation programme information provided to support high level decisions including JAR, ICC, Core group to track progress on NSIPSS Accountability Framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide routine technical support to strengthen partnership, coordination and immunisation programme planning and implemenation at national and sub-national levels focusing on :
  - Development of recovery and catch-up stragegy for routine immunisation
  - strengthening functionality of ICC, NGI-TAG and others to strengthening broader monitoring of Immunisation performance.
  - coordinating and monitoring priority stratgies to reach zero-dose children and unreached communities in the 8 Gavi Focus states and other states
  - supporting the development of a roadmap for improved integration of EPI with other PHC services
  - coordinate the introduction of new vaccine introduction and vaccine specific support including nOPV and related PIE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine Immunisation Performance Shared and Action Plans developed
State Specific AF framework for PSR developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support for integration of EPI and PHC services toward strenthening Health System in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa). 2. Techinical support to map Human Resouce providing routine immunization in high priority LGAs in (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa) so as to support government to develop mitigation plan. 3. Technical Support for introduction of new vaccines (IPV2, Rota).">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">State Annual Workplans Developed focusing on reaching zero dose and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support for integration of EPI and PHC services toward strenthening Health System in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa). 2. Techinical support to map Human Resouce providing routine immunization in high priority LGAs in (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa) so as to support government to develop mitigation plan. 3. Technical Support for introduction of new vaccines (IPV2, Rota).">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Atleast 15% increase number of LGAs in the 18 priority states with acceptable LQAS results at &gt; 80%. 
 3. M&amp;E Framework to track the status of implementation of recommendations from EPI review and Multi-Stakeholder Dialogue (MSD). 3. Concept Note of PIE for IPV, MenA &amp; MCV2.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Provide Technical support to development of costed NERICC workplan that include intervention (IMOP, RI Intensification, Urban vccination, OIRIS) to reach zero dose children. 
  2. Coordinate and develop M&amp;E framework to track implementation of action points from EPI Review/Multi-Stakeholders Dialogue. 
 3. Technical support for conduct of Post Introduction Coverage Survey for IPV, Men A, MCV2.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Atleast 30% of interventions to reach zero dose children on NERICC Annual Workplan containing are achieved. 
 2. Atleast 30% increase number of LGAs in the 18 priority states with acceptable LQAS results at &gt; 80%. 
 3. M&amp;E Framework to track the status of implementation of recommendations from EPI review and Multi-Stakeholder Dialogue (MSD).
 4. PAP/LQAS report.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Provide Technical support to development of costed NERICC workplan that include intervention (IMOP, RI Intensification, Urban vccination, OIRIS) to reach zero dose children. 
  2. Coordinate and develop M&amp;E framework to track implementation of action points from EPI Review/Multi-Stakeholders Dialogue. 
 3. Technical support for conduct of Post Introduction Coverage Survey for IPV, Men A, MCV2.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% districts sanitaires des 04 regions disposent de microplans selon le nouveau guide ACD/CEA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% de districts avec enfants non vaccin&#xE9;s ou des zero doses ont reduit le taux de zero doses ou d&apos;enfants non vaccin&#xE9;s de 50% &#xE0; 20%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strategies particuli&#xE8;res (nomade, desertique, urbaine et d&apos;insecurit&#xE9;) pour identifier et vacciner les enfants zero doses et insuffisaments vaccin&#xE9;s dans les districts prioritaires de 4 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass) en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% de districts ont reduit ce taux de de 50% &#xE0; 20%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strategies particuli&#xE8;res (nomade, desertique, urbaine et d&apos;insecurit&#xE9;) pour identifier et vacciner les enfants zero doses et insuffisaments vaccin&#xE9;s dans les districts prioritaires de 4 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass) en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le draft 0 de la strat&#xE9;gie nationale de vaccination des populations en zone d&#xE9;sertique est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer la strategie nationale d&apos;atteinte et de vaccination des populations situ&#xE9;es en zones desertiques">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">le document valid&#xE9; de la strat&#xE9;gie nationale de vaccination des populations en zone d&#xE9;sertique est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer la strategie nationale d&apos;atteinte et de vaccination des populations situ&#xE9;es en zones desertiques">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">ICA - Claire Sambou : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Le plan annuel du pays est en cours de validation 2. R&#xE9;union sur les cadres de gestion des programmes 3. Soumission du plan de TCA 4. Soutien au parcours d&apos;am&#xE9;lioration de la qualit&#xE9; 5. Approvisionnement en vaccins Covid</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Le plan annuel du pays est en cours de validation
2. R&#xE9;union sur les cadres de gestion des programmes
3. Soumission du plan de TCA
4. Soutien au parcours d&apos;am&#xE9;lioration de la qualit&#xE9;
5. Approvisionnement en vaccins Covid</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Mise en ?uvre des subventions Gavi
2. &#xC9;valuation conjointe annuelle (MSD) de la subvention Gavi
3. Rapports sur le parcours d&apos;am&#xE9;lioration de la qualit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Acquisition et d&#xE9;ploiement du vaccin Covid-19
2. La mise en ?uvre du plan de d&#xE9;ploiement dans le pays
3. Rapports sur le d&#xE9;ploiement du vaccin Covid-19</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Processus de soumission des demandes de vaccin contre la Covid-19, des ECF et de l?AT 2. Pr&#xE9;sentation du plan de d&#xE9;ploiement national 3. R&#xE9;unions de l&apos;&#xE9;quipe de coordination nationale Covid et cadres de coordination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Processus de soumission des demandes de vaccin contre la Covid-19, des ECF et de l?AT
2. Pr&#xE9;sentation du plan de d&#xE9;ploiement national
3. R&#xE9;unions de l&apos;&#xE9;quipe de coordination nationale Covid et cadres de coordination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Johns Hopkins University : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Online survey of socio-behavioural drivers of vaccine uptake conducted and analysis by state produced
? State communication plans that prioritizes demand generation strategies for zero dose children developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of state plans and strategies for behaviour change communication to address zero dose, informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake, stakeholder mapping and knowledge of key influencers.
? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Produce how-to-do short training videos on various immunization skills (e.g. adaptive management processes like after action review, or organizing community listening exercises during HCD) for health workers disseminations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management and human centred design approaches (HCD)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training on adaptive management and use of HCD integrated into approved and funded training activities for national trainers</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management and human centred design approaches (HCD)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Situational analysis report including drivers and correlates of zero dose, mapping of zero dose children produced
? States supported to implement planned funded communication strategies targeting zero-dose children
? Gavi CSO engagement framework adapted for the Nigerian context
? CSO mapping updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of state plans and strategies for behaviour change communication to address zero dose, informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake, stakeholder mapping and knowledge of key influencers.
? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi.">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Expertise France : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report evidencing the modification of the organizational structure and an adaptation of the job descriptions in line with the workplan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of each training session for a total of 8 training sessions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of each guidance mission (for a total of 8) with the integrated distance assistance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of the functional and organizational diagnosis of the decentralized level of the PH Ministry including a capacities reinforcement plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
